Raymond James Financial
PRCT icon

Raymond James Financial’s Procept Biorobotics PRCT Stock Holding History

Raymond James Financial’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,985
Closed -$287K – 6290
2025
Q2 		$287K Sell
4,985
-492
-9% -$27.8K ﹤0.01% 4312
2025
Q1 		$319K Sell
5,477
-14,976
-73% -$1.02M ﹤0.01% 4191
2024
Q4 		$1.65M Buy
+20,453
New +$1.75M ﹤0.01% 3106

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Raymond James Financial's PRCT Position: Q3 2025 in Review

Raymond James Financial sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 4,985 shares — an estimated $287K sold.

Raymond James Financial first reported a position in PRCT in Q4 2024 and held it in 3 quarters. The position peaked at $1.65M in Q4 2024. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • Raymond James Financial reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 4,985 Procept Biorobotics shares in Q3 2025, an estimated $287K.
  • Raymond James Financial first reported a position in Procept Biorobotics in Q4 2024 and held it in 3 quarters.
  • Raymond James Financial's Procept Biorobotics position peaked at $1.65M in Q4 2024.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.